PTGS2 and esophageal squamous cell carcinoma: Our findings support the study of Naoki Hashimoto and Zimmermann [20, 21], who also noticed immuno-expression of COX-2 in ESCC in 91% of the cases and suggested that COX-2 derived prostaglandin plays an important role in the regulation and proliferation of tumor cells [20, 21].